876617-13-9 Usage
Uses
Used in Pharmaceutical Industry:
BOC-(RS)-2-AMINO-4-BENZYLOXYBUTANOIC ACID is used as a building block for the synthesis of various pharmaceuticals and biologically active compounds due to its versatile chemical properties and its role in creating complex organic molecules.
Used in Organic Chemistry Research:
In the realm of organic chemistry, BOC-(RS)-2-AMINO-4-BENZYLOXYBUTANOIC ACID is used as a key intermediate for the development of new chemical entities, contributing to the advancement of scientific knowledge and potential drug discoveries.
Used in Solid-Phase Peptide Synthesis:
BOC-(RS)-2-AMINO-4-BENZYLOXYBUTANOIC ACID is utilized as a stable component in solid-phase peptide synthesis, taking advantage of its selective deprotection properties to facilitate the creation of peptide-based drugs and other bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 876617-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,6,1 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 876617-13:
(8*8)+(7*7)+(6*6)+(5*6)+(4*1)+(3*7)+(2*1)+(1*3)=209
209 % 10 = 9
So 876617-13-9 is a valid CAS Registry Number.
876617-13-9Relevant academic research and scientific papers
Synthesis method of 2,4-diaminobutyric acid derivative
-
, (2021/03/11)
The invention belongs to the field of organic chemistry, and particularly relates to a synthesis method of a 2,4-diaminobutyric acid derivative. According to the synthesis method of the 2,4-diaminobutyric acid and the derivative thereof provided by the invention, homoserine is selected as an initial raw material, the amino and carboxyl of the homoserine are protected firstly, a pht group is introduced through a light delay reaction, and then a final product can be obtained through six steps of benzyl ester removal, pht removal and Boc group removal. According to the invention, the synthetic method provided by the invention has relatively high reaction yield and is convenient for separation and purification; the intermediates obtained in the reaction are all protecting group modified aminoacid derivatives and can be directly used as drug intermediates or raw materials for synthesizing other compounds, so that waste is avoided; and the reaction conditions provided by the invention are mild, and later-period amplification production is facilitated.
